Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/121283
DC FieldValueLanguage
dc.contributor.authorGomila, A.en_US
dc.contributor.authorCarratala, J.en_US
dc.contributor.authorEliakim-Raz, N.en_US
dc.contributor.authorShaw, E.en_US
dc.contributor.authorWiegand, I.en_US
dc.contributor.authorVallejo Torres, Lauraen_US
dc.contributor.authorGorostiza, A.en_US
dc.contributor.authorVigo, JMen_US
dc.contributor.authorMorris, S.en_US
dc.contributor.authorStoddart, M.en_US
dc.contributor.authorGrier, S.en_US
dc.contributor.authorVank, C.en_US
dc.contributor.authorCuperus, N.en_US
dc.contributor.authorVan den Heuvel, L.en_US
dc.contributor.authorVuong, C.en_US
dc.contributor.authorMacGowan, A.en_US
dc.contributor.authorLeibovici, L.en_US
dc.contributor.authorAddy, I.en_US
dc.contributor.authorPujol, M.en_US
dc.date.accessioned2023-03-16T13:28:38Z-
dc.date.available2023-03-16T13:28:38Z-
dc.date.issued2018en_US
dc.identifier.issn1178-6973en_US
dc.identifier.urihttp://hdl.handle.net/10553/121283-
dc.description.abstractPurpose: Complicated urinary tract infections (cUTIs) are among the most frequent healthcare-associated infections. In patients with cUTI, Pseudomonas aeruginosa deserves special attention, since it can affect patients with serious underlying conditions. Our aim was to gain insight into the risk factors and prognosis of P. aeruginosa cUTIs in a scenario of increasing multidrug resistance (MDR). Methods: This was a multinational, retrospective, observational study at 20 hospitals in south and southeastern Europe, Turkey, and Israel including consecutive patients with cUTI hospitalized between January 2013 and December 2014. A mixed-effect logistic regression model was performed to assess risk factors for P. aeruginosa and MDR P. aeruginosa cUTI. Results: Of 1,007 episodes of cUTI, 97 (9.6%) were due to P. aeruginosa. Resistance rates of P. aeruginosa were: antipseudomonal cephalosporins 35 of 97 (36.1%), aminoglycosides 30 of 97 (30.9%), piperacillin–tazobactam 21 of 97 (21.6%), fluoroquinolones 43 of 97 (44.3%), and carbapenems 28 of 97 (28.8%). The MDR rate was 28 of 97 (28.8%). Independent risk factors for P. aeruginosa cUTI were male sex (OR 2.61, 95% CI 1.60–4.27), steroid therapy (OR 2.40, 95% CI 1.10–5.27), bedridden functional status (OR 1.79, 95% CI 0.99–3.25), antibiotic treatment within the previous 30 days (OR 2.34, 95% CI 1.38–3.94), indwelling urinary catheter (OR 2.41, 95% CI 1.43–4.08), and procedures that anatomically modified the urinary tract (OR 2.01, 95% CI 1.04–3.87). Independent risk factors for MDR P. aeruginosa cUTI were age (OR 0.96, 95% CI 0.93–0.99) and anatomical urinary tract modification (OR 4.75, 95% CI 1.06–21.26). Readmission was higher in P. aeruginosa cUTI patients than in other etiologies (23 of 97 [23.7%] vs 144 of 910 [15.8%], P=0.04), while 30-day mortality was not significantly different (seven of 97 [7.2%] vs 77 of 910 [8.5%], P=0.6). Conclusion: Patients with P. aeruginosa cUTI had characteristically a serious baseline condition and manipulation of the urinary tract, although their mortality was not higher than that of patients with cUTI caused by other etiologies.en_US
dc.languageengen_US
dc.relation.ispartofInfection and Drug Resistanceen_US
dc.sourceInfection and Drug Resistance [ISSN 1178-6973], v. 2018 (11), p. 2571—2581, (2018)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320505 Enfermedades infecciosasen_US
dc.subject.otherHealth care-associated infectionsen_US
dc.subject.otherComplicated urinary tract infectionsen_US
dc.subject.otherPseudomonas aeruginosaen_US
dc.subject.otherMultidrug-resistanceen_US
dc.titleRisk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort studyen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.2147/IDR.S185753en_US
dc.identifier.scopus2-s2.0-85064759664-
dc.identifier.isiWOS:000453782100001-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.description.lastpage2581en_US
dc.description.firstpage2571en_US
dc.relation.volume2018en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages12en_US
dc.utils.revisionen_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,354
dc.description.jcr3,0
dc.description.sjrqQ1
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR Economía de la salud y políticas públicas-
crisitem.author.deptDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.orcid0000-0001-5833-6066-
crisitem.author.parentorgDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.fullNameVallejo Torres, Laura-
Appears in Collections:Artículos
Adobe PDF (462,75 kB)
Show simple item record

SCOPUSTM   
Citations

28
checked on Nov 17, 2024

WEB OF SCIENCETM
Citations

28
checked on Nov 17, 2024

Page view(s)

62
checked on Jul 27, 2024

Download(s)

102
checked on Jul 27, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.